Skip to main content
رجوع
Watch Compare

Zentalis Pharmaceuticals, Inc.

جودة البيانات: 100%
ZNTL
Nasdaq Manufacturing Chemicals
KWD 4.47
▲ KWD 1.71 (61.96%)
القيمة السوقية: 317.05 M
السعر
KWD 4.47
القيمة السوقية
317.05 M
نطاق اليوم
KWD 2.86 — KWD 4.47
نطاق 52 أسبوعًا
KWD 1.06 — KWD 4.47
حجم التداول
11,003,944
فتح KWD 3.02
متوسط 50 يوم / 200 يوم
KWD 2.52
77.08% above
متوسط 50 يوم / 200 يوم
KWD 1.82
145.11% above

Quick Summary

النقاط الرئيسية

Negative free cash flow of -125.25 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)-100.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-51.98%
أعلى من متوسط القطاع (-53.47%)
ROIC-40.05%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio7.76
Interest CoverageN/A

التقييم

PE (TTM)
-2.31
أقل من متوسط القطاع (-1.47)
P/B Ratio1.25
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -2.3 -1.5
P/B 1.3 1.6
ROE % -52.0 -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

ETFs Holding This Stock

BRSIX BRSIX
0.25% weight
FSCC logo FSCC Federated Hermes MDT Small Cap Core ETF
0.07% weight
GSCYX GSCYX
0.01% weight
GSCZX GSCZX
0.01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -100.00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -137.06 M
ROE -51.98% ROA -40.37%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -125.25 M
ROIC -40.05% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 7.76
Interest Coverage N/A Asset Turnover 0.00
Working Capital 251.13 M Tangible Book Value 252.87 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.31 Forward P/E N/A
P/B Ratio 1.25 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -39.50%
Market Cap 317.05 M Enterprise Value 277.98 M
Per Share
EPS (Diluted TTM) -1.91 Revenue / Share 0.00
FCF / Share -1.77 OCF / Share -1.77
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 91.38%
SBC-Adj. FCF -153.21 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 67.43 M — — —
Net Income -137.06 M -165.84 M -292.19 M -236.81 M -158.73 M
EPS (Diluted) -1.91 -2.33 -4.47 -4.48 0.00
Gross Profit — — — — —
Operating Income -152.81 M -191.19 M -299.51 M -227.29 M -216.54 M
EBITDA — — — — —
R&D Expenses 107.30 M 167.77 M 189.59 M 172.73 M 175.60 M
SG&A Expenses — — — — —
D&A 739,000.0 1.29 M 1.39 M 1.43 M 544,000.0
Interest Expense — — — — —
Income Tax 442,000.0 177,000.0 -601,000.0 -469,000.0 -297,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 288.97 M 430.34 M 551.69 M 539.31 M 454.51 M
Total Liabilities 72.76 M 93.15 M 114.30 M 105.29 M 90.03 M
Shareholders' Equity 216.20 M 337.19 M 437.28 M 434.02 M 364.48 M
Total Debt — — — — —
Cash & Equivalents 36.00 M 33.90 M 28.04 M 43.07 M 59.71 M
Current Assets 253.19 M 386.07 M 496.72 M 451.93 M 350.77 M
Current Liabilities 36.56 M 52.73 M 69.37 M 56.65 M 43.94 M